Charles River Laboratories International, Inc. (NYSE: CRL) has acquired Celsis International Ltd.

Target Company Name:
Country:
Advisory:
Sector:
Partner:
Celsis International Ltd.
USA
Advisor to the seller
Healthcare & Pharmaceuticals
Brown Gibbons Lang & Company

Sale of Celsis International Ltd., a private equity portfolio company, to Charles River Laboratories International, Inc. (NYSE: CRL) for $212 million

Celsis International Ltd.
Charles River Laboratories International, Inc. (NYSE: CRL)
Sale of Celsis International Ltd. to Charles River Laboratories International, Inc.
logo
Advisor to the seller :
Brown Gibbons Lang & Company

Experts who worked on this transaction

John Riddle

John Riddle

Managing Director & Principal at Brown Gibbons Lang & Company

Relevant transactions

Transactions
Project Amygdala
Private Equity
Sale of mental health services provider for high-acuity individuals in the UK
logo
Advisor to the seller :
Cooper Parry Corporate Finance
Genbio
Private Investors
Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors
logo
Advisor to the seller :
RIóN
icotec
MVM Partners
icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM
logo
Advisor
Alpha Source Group
Probo Medical
Alpha Source Group, a portfolio company of Baird Capital, acquired by Probo Medical.
logo
Advisor to the seller :
Brown Gibbons Lang & Company

REACH Cross-Border Mergers & Acquisitions is a worldwide partnership of 24 M&A advisory firms operating across 30 countries.

REACH Cross-Border Mergers & Acquisitions Logo with tagline Terms & Conditions
Privacy Policy

© 2024 REACH Cross-Border Mergers & Acquisitions